A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients

American Journal of Surgical Pathology

Volumn 38, Issue 6, 2014, Pages 832-843

  Doyle, Leona A ^a   Sepehr, Golrokh J ^a   Hamilton, Matthew J ^a   Akin, Cem ^a   Castells, Mariana C ^a   Hornick, Jason L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Gastrointestinal tract; Irritable bowel syndrome; KIT; Liver; Mast cell activation syndrome; Mast cells; Mastocytosis; Urticaria pigmentosa

Indexed keywords

BIOLOGICAL MARKER; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BIOPSY; CASE CONTROL STUDY; CELL COUNT; CHEMISTRY; CHRONIC DISEASE; COLONOSCOPY; COMPARATIVE STUDY; DIARRHEA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; IRRITABLE COLON; MALE; MAST CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SYSTEMIC MASTOCYTOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CELL COUNT; CHRONIC DISEASE; COLONOSCOPY; DIARRHEA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-KIT; YOUNG ADULT;

EID: 84900873831     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000190     Document Type: Article

References (30)

1. Jensen RT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am. 2000;14: 579-623
2. Topar G, Staudacher C, Geisen F, et al. Urticaria pigmentosa: A clinical, hematopathologic, and serologic study of 30 adults. Am J Clin Pathol. 1998;109:279-285
3. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008
4. Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med. 2004; 55:419-432
5. Ammann RW, Vetter D, Deyhle P, et al. Gastrointestinal involvement in systemic mastocytosis. Gut. 1976;17:107-112
6. Arguedas MR, Ferrante D. Systemic mastocytosis and giant gastroduodenal ulcer. Gastrointest Endosc. 2001;54:530-533
7. Bedeir A, Jukic DM, Wang L, et al. Systemic mastocytosis mimicking inflammatory bowel disease: A case report and discussion of gastrointestinal pathology in systemic mastocytosis. Am J Surg Pathol. 2006;30:1478-1482
8. Behdad A, Owens SR. Systemic mastocytosis involving the gastrointestinal tract: Case report and review. Arch Pathol Lab Med. 2013;137:1220-1223
9. Hahn HP, Hornick JL. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol. 2007;31:1669-1676
10. Kirsch R, Geboes K, Shepherd NA, et al. Systemic mastocytosis involving the gastrointestinal tract: Clinicopathologic and molecular study of five cases. Mod Pathol. 2008;21:1508-1516
11. Lee JK, Whittaker SJ, Enns RA, et al. Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol. 2008;14: 7005-7008
12. Tebbe B, Stavropoulos PG, Krasagakis K, et al. Cutaneous mastocytosis in adults. Evaluation of 14 patients with respect to systemic disease manifestations. Dermatology. 1998;197:101-108
13. Sokol H, Georgin-Lavialle S, Canioni D, et al. Gastrointestinal manifestations in mastocytosis: A study of 83 patients. J Allergy Clin Immunol. 2013;132:866-873. e3
14. Jakate S, Demeo M, John R, et al. Mastocytic enterocolitis: Increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med. 2006;130:362-367
15. Akhavein MA, Patel NR, Muniyappa PK, et al. Allergic mastocytic gastroenteritis and colitis: An unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterol Res Pract. 2012;2012:950582
16. Hamilton MJ, Hornick JL, Akin C, et al. Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol. 2011;128:147-152
17. Valent P, Akin C, Sperr WR, et al. Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria. Leuk Res. 2003;27:635-641
18. Valent P, Akin C, Sperr WR, et al. Mastocytosis: Pathology, genetics, and current options for therapy. Leuk Lymphoma. 2005;46:35-48
19. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res. 2001; 25:603-625
20. Sotlar K, Cerny-Reiterer S, Petat-Dutter K, et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol. 2011;24:585-595
21. Berezowska S, Flaig MJ, Rueff F, et al. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Mod Pathol. 2014;27:19-29
22. Carter MC, Metcalfe DD. Paediatric mastocytosis. Arch Dis Child. 2002;86:315-319
23. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood. 2006;108:2366-2372
24. Ma Y, Zeng S, Metcalfe DD, et al. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-Type kinases and those with regulatory-Type mutations. Blood. 2002;99:1741-1744
25. Zermati Y, De Sepulveda P, Feger F, et al. Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-Type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene. 2003;22:660-664
26. Krokowski M, Sotlar K, Krauth MT, et al. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: Value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia. Am J Clin Pathol. 2005;124:560-568
27. Sotlar K, Horny HP, Simonitsch I, et al. CD25 indicates the neoplastic phenotype of mast cells: A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol. 2004; 28:1319-1325
28. Escribano L, Orfao A, Villarrubia J, et al. Immunophenotypic characterization of human bone marrow mast cells A flow cytometric study of normal and pathological bone marrow samples. Anal Cell Pathol. 1998;16:151-159
29. Krauth MT, Majlesi Y, Florian S, et al. Cell surface membrane antigen phenotype of human gastrointestinal mast cells. Int Arch Allergy Immunol. 2005;138:111-120
30. Scolapio JS, Wolfe J 3rd, Malavet P, et al. Endoscopic findings in systemic mastocytosis. Gastrointest Endosc. 1996;44:608-610.